Pluri Inc. faces potential Nasdaq delisting over equity shortfall - Investing.com
Pluri Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.32
-7.9% in 7d after detection
Post-detection moves
1h
—
1d
+3.2%
3d
-5.8%
7d
-7.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS